Medical Necessity Assessment for Spinal Cord Stimulator Trial

Critical Missing Documentation

The American Society of Anesthesiologists explicitly requires favorable psychological evaluation, absence of untreated psychiatric comorbidity, or current treatment in a multidisciplinary pain management program before SCS trial 1
No documentation of duration, specific medications tried, dosages, or compliance for conservative treatment, which is a mandatory criterion 1
No evidence of structured physical therapy program, which is a required treatment before considering spinal cord stimulation 1
No documentation of trials with first-line neuropathic pain medications, such as gabapentinoids, tricyclic antidepressants, or SNRIs, as recommended by the Mayo Clinic Proceedings 2
No documentation excluding coagulopathy, anticoagulant/antiplatelet therapy, or thrombocytopenia, which is a critical safety requirement before any epidural procedure 1
No documentation that the patient is capable of operating the stimulating device, which is essential for successful outcomes 1

Lumbar MRI shows "widely patent" spinal canal at all levels with "no evidence of any neural impingement", which contradicts the diagnosis of lumbar radiculopathy requiring neuromodulation 3
The L5-S1 degenerative changes described do not correlate with documented neural compression, as reported in the Journal of Neurosurgery 3
The indication appears more appropriate for continued cervical-focused interventions rather than lumbar SCS trial, based on the patient's cervical MRI and response to cervical selective nerve root block 1

The American Society of Anesthesiologists recommends considering pulsed radiofrequency treatment adjacent to the dorsal root ganglion before proceeding to SCS, but this was not documented 1
Spinal cord stimulation is specifically recommended for therapy-resistant radicular pain in the context of Failed Back Surgery Syndrome, but this patient does not have documented failed back surgery syndrome 1
Trials of neuropathic pain medications, such as gabapentin, pregabalin, duloxetine, or tricyclics, should be documented before considering SCS, as recommended by the Mayo Clinic Proceedings 2

No validated outcome measures, such as VAS or ODI, were documented at baseline, making it impossible to objectively measure trial success, as reported in the Journal of Neurosurgery 3
Hardware-related complications, including infection risk, must be carefully considered before proceeding with SCS, with a reported risk of 10-29% 3

The American Society of Anesthesiologists guidelines require psychological clearance, documented trials of first-line neuropathic pain medications, structured physical therapy program, coagulation studies, and baseline validated outcome measures before considering SCS trial 1
The Mayo Clinic Proceedings recommend documenting trials of neuropathic pain medications, such as gabapentinoids, tricyclic antidepressants, or SNRIs, before considering SCS 2
The Journal of Neurosurgery reports that lumbar MRI findings should correlate with documented neural compression, and that validated outcome measures should be documented at baseline 3

The American Society of Anesthesiologists recommends spinal cord stimulation not as a first-line treatment for pain related to tethered cord syndrome, adhesive arachnoiditis, or osteomyelitis due to limited evidence of efficacy 4

For osteomyelitis-related pain, there is no specific evidence supporting spinal cord stimulation 5
For focal pain in limited dermatomes, which may include some cases of osteomyelitis pain, spinal neurolytic blocks may be more appropriate than stimulation 6
Conventional medical management, including appropriate analgesics, should be tried before considering spinal cord stimulation, as per the American Society of Anesthesiologists 4
Physical therapy and conservative measures should also be attempted before considering spinal cord stimulation 4

The American Society of Anesthesiologists suggests considering spinal neurolytic blocks for focal pain in limited dermatomes, especially for one-sided pain 6
For neuropathic components, a trial of peripheral nerve stimulation may be considered for peripheral nerve injuries, according to the American Society of Anesthesiologists 4
Spinal cord stimulation should only be considered if the patient has failed all conservative treatments, pain is predominantly neuropathic in nature, and there are no psychological contraindications 4, 7

Hardware-related complications, including lead migration and connection issues, occur in 10-29% of cases 7
Infection risk, especially in patients with active osteomyelitis, must be carefully considered 7
The potential need for revision surgery should be discussed with patients 7

The British Journal of Anaesthesia recommends a minimum of 3 months of conservative management for non-severe radicular pain, including trials of simple analgesics and NSAIDs, before considering spinal cord stimulation 8, 9
Image-guided epidural steroid injections using fluoroscopic guidance should be attempted before spinal cord stimulation, as recommended by the British Journal of Anaesthesia 8, 9, 10
For severe radicular pain with neurological deficit, earlier referral within 2 weeks may be appropriate for image-guided injections or surgery, according to the British Journal of Anaesthesia 8, 9
Less severe radicular pain should be referred to specialist services no later than 3 months, as suggested by the British Journal of Anaesthesia 8, 9

Imaging findings must correlate with documented neural compression and clinical presentation, and should be interpreted by specialists with skills to organize, interpret, and act on findings, as recommended by the British Journal of Anaesthesia 8, 10